Skip to main content
Contact Us
Subscribe
E-Edition
82°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclaris Therapts
(NQ:
ACRS
)
1.140
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.140
Bid (Size)
1.110 (6)
Ask (Size)
1.240 (1)
Prev. Close
1.140
Today's Range
1.140 - 1.140
52wk Range
0.5902 - 11.12
Shares Outstanding
71,264,786
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 24, 2024
Via
Benzinga
Performance
YTD
+8.57%
+8.57%
1 Month
+9.62%
+9.62%
3 Month
-6.56%
-6.56%
6 Month
+8.57%
+8.57%
1 Year
-89.11%
-89.11%
More News
Read More
ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
Via
FinancialNewsMedia
Aclaris Therapeutics: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Aclaris Therapeutics
January 11, 2024
Via
Benzinga
Breaking Down Aclaris Therapeutics: 6 Analysts Share Their Views
December 18, 2023
Via
Benzinga
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
March 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
Via
Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Via
Benzinga
Aclaris Therapeutics Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
December 18, 2023
Via
Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
January 16, 2024
Via
Benzinga
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Via
Benzinga
Crude Oil Falls 1%; Amarin Shares Spike Higher
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial
January 10, 2024
Via
Benzinga
Dow Surges 100 Points; PriceSmart Earnings Top Views
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 10, 2024
Via
Benzinga
Inflammatory Disease Focused Aclaris Therapeutics Reduces Staff After Failed Psoriatic Arthritis Study
December 20, 2023
Via
Benzinga
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
December 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 05, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.